Operating income before deduction of amortization: LB Pharmaceuticals, Inc. (LBRX)

Brandmark of LB Pharmaceuticals (LBRX)

EBITDA volatility reflects current trends, with the value fixed at 0.00. LB Pharmaceuticals Inc management is focused on developing safe treatments for mental disorders. Stability is maintained through strict control of R&D expenses and transparent protocols. The foundation for growth is an innovative pipeline of next-generation antipsychotics preparing for final trials in the US.

LB Pharmaceuticals Inc (LBRX) Operating profit EBITDA: for the period 11/23/2025 - 11/11/2026

Summary analytical data breakdowns for LB Pharmaceuticals (LBRX)

- share price and consensus valuation forecast:
Quote Chart LB Corp|LBRX - Price Target Chart
- company stock exchange capitalization indicators:
Market Capitalization LB Pharmaceuticals|LBRX - Real Price to Acquire Entire Company
- balance sheet equity data:
Net Asset Value per Share LB Pharmaceuticals|LBRX - Book Capitalization|Market Cap to Net Assets Ratio lbpharma.us|LBRX - Company Total Assets
- company total debt and liquidity indicators:
All Debt to Shareholders' Equity Ratio LB Pharmaceuticals Inc|LBRX - Long-Term Debt to Equity|Current Liabilities to Capital LB Pharmaceuticals, Inc.|LBRX - Company Debts|Debt to Book Capitalization Ratio LB Pharmaceuticals|LBRX - Company Long-Term Debts|Company Short-Term Debt LB Pharmaceuticals|Intermediate Coverage Ratio lbpharma.us
- earnings and market multiples details:
LBRX - Company Net Income|Forward Earnings LB Pharmaceuticals Inc|LBRX - P/E Multiple|Future Price to Earnings Multiple lbpharma.us|LBRX - PEG Multiple|EV/EBITDA Multiple LB Pharmaceuticals|LBRX - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year LB Pharmaceuticals|LBRX - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months lbpharma.us|LBRX - Earnings growth in current year|Earnings growth forecast for next year LB Pharmaceuticals Inc
Analysis of all company metrics:LB Corp (LBRX)
Brand item of LB Pharmaceuticals Inc

This indicator measures a business's ability to generate cash flow to cover the cost of capital, where any historical peak without production scaling signals efficiency stagnation. By analyzing the operating profit summary, an investor discounts the future earnings of LB Pharmaceuticals Inc (LBRX), assessing the success of new drug delivery methods amid stable, GDP-independent demand for psychotropic drugs.

Who LB Pharmaceuticals Inc competes with

ALKS (Alkermes Corp) - Profit before deduction of interest, taxes, depreciation and amortization|AVDL - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization atai.life ATAI|GHRS (GH Research) - Operating profit before deduction of amortization|Profit before interest, taxes and amortization Mind Medicine (MindMed) Inc. (MNMD)|CMPS (Compass Pathways) - Operating profit EBITDA|Operating profit before deduction of amortization Bright Minds Corp (DRUG)|Operating profit EBITDA VNDA|CYBN (cybin.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Alto Neuroscience ANRO|NRx Pharmaceuticals Inc. (NRXP) - Profit before interest, taxes and amortization|CING - Profit before payment of interest, taxes and amortization|SILO: Profit before payment of interest, taxes and amortization|CPHI: Operating profit EBITDA|CMND (clearmindmedicine.com) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization PBM|SPRC: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Seelos Therapeutics, Inc (SEEL)|VRPX: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA KRTX (Karuna Therapeutics)